Crossmark

Effect of antisecretory factor, given as a food supplement to adult patients with severe traumatic brain injury (SASAT): protocol for an exploratory randomized double blind placebo-controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06275-z

Published Online: 2022-04-23

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cederberg, David http://orcid.org/0000-0002-7491-3115
Harrington, Bradley M.

Vlok, Adriaan Johannes

Siesjö, Peter
Funding

Funding for this research was provided by:

Skånes universitetssjukhus

Lund University
License Information

Text and Data Mining valid from 2022-04-23

Version of Record valid from 2022-04-23
More Information

Article History

Received: 30 April 2021

Accepted: 3 April 2022

First Online: 23 April 2022

Declarations

:

: See ethics part

: When the patient/next of kin is informed of the trial, information is given about the intent of publishing the results, and if consent is given for participation in the trial, consent for publications is given as well.

: The authors declare that they have no competing interests

Document is current

Any future updates will be listed below